Dupixent approved as the first-ever biologic medicine in Japan for patients with COPDFollowing recent approvals in the EU, China, and the US, ...

Dupixent approved as the first-ever biologic medicine in Japan for patients with COPD Following recent approvals in the EU, China, and the US, this approval was based on pivotal phase 3 results in adu ...

The Ministry of Health, Labour and Welfare in Japan has granted marketing and manufacturing authorization for Dupixent (dupilumab) for the treatment of chronic obstructive pulmonary disease (COPD) in ...

Following recent approvals in the EU, China and the U.S., this approval was based on pivotal Phase 3 results in adults with elevated eosinophils ...

While the Inflation Reduction Act’s drug pricing provisions have disrupted seniors’ healthcare, the passage of the EPIC Act ...

The world’s largest multidisciplinary scientific society honored Brown faculty members from molecular biophysics and ...

Getting prior authorization for medications can be a struggle in allergy and asthma care, but creating templates and paying attention to detail can speed up the process and lead to more success, ...

The Weill Family Foundation is giving $50 million to enable 4 leading research institutions to form the Weill Cancer Hub East ...

Certain widely used drug combinations may either slow down or worsen the progression of Alzheimer's disease, but their ...

A Dundee academic has been awarded a prestigious national prize for his work on neurodegenerative diseases, including ...

A doctor who studies more than 10,000 centenarians is learning new insights that may help to slow aging in everybody.

Nitisinone, a drug for rare diseases, kills mosquitoes when present in human blood and may become a new tool to fight malaria ...